Godrej Agrovet Limited announced its financial results for the second quarter and first half of FY27, ending September 30, 2026. The company reported a strong 17% year-on-year revenue growth for Q2 FY27, reaching ₹2,995 crore. Profit After Tax (PAT) saw a significant increase of 22%, reaching ₹103 crore, despite input cost inflation impacting EBITDA.
Godrej Agrovet Announces Strong Q2 FY27 Financial Performance
Godrej Agrovet Limited (GAVL) has announced its financial results for the second quarter (Q2) and the first half (H1) of the financial year 2027, which ended on September 30, 2026. The company reported robust double-digit revenue growth amidst a challenging operating environment.
Q2 FY27 Highlights
In Q2 FY27, GAVL’s revenue surged by 17% year-on-year to ₹2,995 crore, driven by strong performances in its Animal Nutrition, Oil Palm, and B2C foods segments. This growth was fueled by higher realizations and volumes across key business verticals. While EBITDA remained flat at ₹222 crore, impacted by input cost inflation and El Niño, Profit Before Tax (PBT) increased by 5% to ₹131 crore. Profit After Tax (PAT) showed a significant rise of 22%, reaching ₹103 crore. The company also highlighted strong working capital management, with receivables at 21 days compared to 32 days in the previous year.
H1 FY27 Performance
For the first half of FY27, revenue grew by 13% to ₹5,847 crore, led by Oil Palm and Animal Nutrition. However, EBITDA, PBT, and PAT saw a slight decline of 5%, 4%, and 1% respectively compared to the previous year, primarily due to prevailing market conditions.
Segment-Wise Performance
Key business segments demonstrated varied growth. Animal Nutrition revenue grew 14% with a 32% increase in segment results. Oil Palm revenue saw a 28% increase, with segment results up 4%. Crop Care revenue rose by 42%, albeit with margin pressure. Astec LifeSciences experienced a revenue decline of ~3%. Creamline Dairy reported a 6% topline growth, while Godrej Foods achieved 8% revenue growth, with its B2C segment up by approximately 50%. The ACI-GAVL joint venture in Bangladesh reported a significant revenue increase of 32%.
Managing Director’s Comments
Mr. Sunil Kataria, Chief Executive Officer & Managing Director, GAVL, commented, “Godrej Agrovet delivered a strong Q2 FY27 despite a challenging macro-operating environment, marked by El Niño-related weather disruptions, unprecedented geopolitical volatility and inflationary pressures. Consolidated revenue grew 17% and PAT rose 22%, even as input cost inflation held EBITDA flat.” He further emphasized the company’s strategic transformation and commitment to creating sustainable long-term value.
Investor Call Details
A conference call for investors to discuss the Q2 and H1 FY27 results was scheduled for Friday, November 6, 2026, at 16:00 hrs IST. Dial-in details and registration links were provided for participants.
Source: BSE
